| Characteristic |
I, T1
|
I, T2
|
I, T3
|
I, T4
|
II, T1
|
II, T2
|
II, T3
|
II, T4
|
III, T1
|
III, T2
|
III, T3
|
III, T4
|
||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| N | Drug A N = 81 |
Drug B N = 91 |
p-value2 | N | Drug A N = 81 |
Drug B N = 101 |
p-value2 | N | Drug A N = 111 |
Drug B N = 71 |
p-value2 | N | Drug A N = 81 |
Drug B N = 71 |
p-value2 | N | Drug A N = 141 |
Drug B N = 91 |
p-value2 | N | Drug A N = 81 |
Drug B N = 91 |
p-value2 | N | Drug A N = 51 |
Drug B N = 61 |
p-value2 | N | Drug A N = 51 |
Drug B N = 121 |
p-value2 | N | Drug A N = 61 |
Drug B N = 71 |
p-value2 | N | Drug A N = 91 |
Drug B N = 101 |
p-value2 | N | Drug A N = 61 |
Drug B N = 81 |
p-value2 | N | Drug A N = 101 |
Drug B N = 81 |
p-value2 | |
| Tumor Response | 17 | 1 (13%) | 5 (56%) | 0.13 | 17 | 3 (38%) | 1 (11%) | 0.3 | 18 | 4 (36%) | 3 (43%) | >0.9 | 15 | 0 (0%) | 4 (57%) | 0.026 | 22 | 3 (21%) | 3 (38%) | 0.6 | 16 | 1 (14%) | 3 (33%) | 0.6 | 9 | 1 (25%) | 3 (60%) | 0.5 | 16 | 2 (40%) | 3 (27%) | >0.9 | 13 | 3 (50%) | 3 (43%) | >0.9 | 19 | 2 (22%) | 3 (30%) | >0.9 | 13 | 3 (60%) | 1 (13%) | 0.2 | 18 | 5 (50%) | 1 (13%) | 0.2 |
| 1 n (%) | ||||||||||||||||||||||||||||||||||||||||||||||||
| 2 Fisher’s exact test | ||||||||||||||||||||||||||||||||||||||||||||||||